CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Pegylated Interferon +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00226447
NCT00226447Phase 2Completed
CompareCT.gov

A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B

Chinese University of Hong Kong·interventional·Posted Sep 27, 2005·Updated Oct 24, 2008

In Brief

A Phase 2 clinical trial evaluating Pegylated Interferon and Lamivudine for Chronic Hepatitis B. Completed, across 1 site.

Detailed Summary

The aim is to investigate the best treatment regime of PEG-Intron A and lamivudine combination in terms of viral clearance in chronic hepatitis B patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis B
CountriesChina
CollaboratorsHoffmann-La Roche, GlaxoSmithKline

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 27, 2005
Enrollment StartDec 1, 2002
Primary CompletionJul 1, 2006
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 20.8 years ago

Interventions

Pegylated Interferondrug

Lamivudinedrug